In conclusion, our findings highlight a modulation of CA III and CA IX expression in the crosstalk occurring between ACC and adipose stem cells, which might represent a putative target for the development of novel anticancer therapies directed against ACC adipose tumor microenvironment. This evidence concerns the gene CA3 and adrenal cortex carcinoma.